Abstract:Background: Aging is the most significant contributor to the increasing prevalence of atrial fibrillation (AF). The gut microbiota dysbiosis is involved in age-associated diseases. However, whether age-associated gut microbial dysbiosis contributes to AF is still unknown. The aim of this study was to evaluate the effect of gut microbiota on the susceptibility of aging-induced AF and to elucidate the underlying mechanisms. Results: The gut microbiota profiling of fecal samples in aged (22-24 months old) and young (2-3 months old) rats was performed by 16S ribosomal RNA gene analysis. A rat model of fecal microbiota transplantation (FMT) was established for analyzing the possible role of age-associated gut microbial dysbiosis in AF. Here, we found that aging process led to marked shift of the microbiota spectrum. The microbiota in young rats following FMT resembled that of aged microbiota and transmitted the increased AF susceptibility by elevation of circulating lipopolysaccharide (LPS). The mechanism for LPS-driven atrial pro-arrhythmic action was dependent on the activation of atrial nucleotide binding and oligomerization domain-like receptor family pyrin domain-containing (NLRP3)-inflammasome. Inhibition of inflammasome by MCC950 resulted in lower atrial fibrosis and AF susceptibility. In addition, atrial fibrosis, plasma LPS concentration, plasma glucose to oral glucose tolerance test (OGTT), intestinal permeability, and gut pathology were significantly increased in elderly human subjects. Finally, altering the microbiota in aged recipient to resemble that of young restored the intestinal barrier dysfunction and LPS and impaired glucose tolerance, and the worse outcomes of aged dysbiosis on atrial fibrosis and AF susceptibility were abrogated. Conclusions: These data suggest that age-associated microbial dysbiosis induces circulating LPS and impairs glucose tolerance, and thereby promotes AF susceptibility through enhanced activity of atrial NLRP3-inflammasome.

Does gut microbiota affect atrial rhythm? Causalities and speculations

Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies

Gut Microbiota Dysbiosis Induced by a High-Fat Diet Increases Susceptibility to Atrial Fibrillation

Roles of gut microbiota in atrial fibrillation: insights from Mendelian randomization analysis and genetic data from over 430,000 cohort study participants

Association of gut microbiome dysbiosis with the progression of atrial fibrillation: A systematic review

Gut microbiota-derived metabolites in atrial fibrillation: risk markers or modifiable risk factors?

Abstract 18307: Causal Association Between Gut Microbiota Composition and the Risk of Atrial Fibrillation

Disordered gut microbiota promotes atrial fibrillation by aggravated conduction disturbance and unbalanced Linoleic acid/SIRT1 signaling

Age-Related Changes in the Gut Microbiota Promote Atrial Fibrillation

Changes of the gut microbiota composition and short chain fatty acid in patients with atrial fibrillation

Different Types of Atrial Fibrillation Share Patterns of Gut Microbiota Dysbiosis

Gut Microbiota and Metabolites in Atrial Fibrillation Patients and Their Changes after Catheter Ablation

Aggravated Gut Microbiota and Metabolomic Imbalances Are Associated with Hypertension Patients Comorbid with Atrial Fibrillation

Gut microbiota and cardiac arrhythmia

Contribution of Diet to Gut Microbiota and Related Host Cardiometabolic Health: Diet-Gut Interaction in Human Health.

Altered synthesis of genes associated with short-chain fatty acids in the gut of patients with atrial fibrillation

Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling

Impact of age-related gut microbiota dysbiosis and reduced short-chain fatty acids on the autonomic nervous system and atrial fibrillation in rats

Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review)

Putative causal relations among gut flora, serums metabolites and arrhythmia: a Mendelian randomization study

Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients